How is the Heron Therapeutics Inc today?

The Heron Therapeutics Inc today is trading in the green, up by 1.00% at 2.02.

How has Heron Therapeutics Inc performed historically?

The Heron Therapeutics Inc is currently trading up 1.00% on an intraday basis in the past week the index rose 6.88%. The index has been down -9.82% in the past quarter and fell -47.67% in the past year. You can view this in the overview section.

What is Heron Therapeutics Inc Annual Revenue?

Heron Therapeutics Inc Annual Revenue rose 13.57%, in the last year to $144.28 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Heron Therapeutics Inc Annual Net Profit?

Heron Therapeutics Inc Annual Net Profit rose 87.72% in the last year to $13.58 M. Its sector's average net profit growth for the last fiscal year was -13.88%.

What is Heron Therapeutics Inc Price to Earning Ratio?

Heron Therapeutics Inc Price to Earning Ratio is -39.58, which is negative.

What is Heron Therapeutics Inc Stock Price?

Heron Therapeutics Inc Stock Price fell 47.67% and underperformed its sector by 79.04% in the past year.

What is Heron Therapeutics Inc Quarterly Revenue?

Heron Therapeutics Inc Quarterly Revenue rose 12.21% YoY to $38.9 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Heron Therapeutics Inc Quarterly Net profit?

Heron Therapeutics Inc Quarterly Net profit rose 183.39% YoY to $2.64 M. Its sector's average net profit growth YoY for the quarter was -238.37%.

What is Heron Therapeutics Inc Mutual Fund Holding?

Heron Therapeutics Inc Mutual Fund Holding increased by 0.32% in the last quarter to 27.82.

What is Heron Therapeutics Inc Promoter Share Holding?

Heron Therapeutics Inc Promoter Share Holding increased by 0.16% in the most recent quarter to 1.48%.

What is Heron Therapeutics Inc Interest Coverage Ratio?

Heron Therapeutics Inc Interest Coverage Ratio is -1.25, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Heron Therapeutics Inc Institutional Holding?

Heron Therapeutics Inc Institutional Holding increased by 5.5% in the last quarter to 81.13.

Heron Therapeutics Inc XNAS: HRTX

Heron Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Heron Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Heron Therapeutics Inc
Rating: 1.80275
Author: Trendlyne DVM scores

about

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, Z...

2.02 0.02 (1.00%)

48.60% Fall from 52W High

383.8K XNAS Volume

XNAS 04 Jun, 2025 12:57 PM (EDT)

Board Meeting

The next board meeting for Heron Therapeutics Inc is on 13 Jun 2025 for the purpose of Heron Therapeutics Inc Annual General Meeting for 2025 See details

Not Eligible

Expensive Valuation

12.5 / 100

Technically Neutral

59.6 / 100

1Yr Price target upside is 213%

3 analysts

Heron Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Heron Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, Z...

48.60% Fall from 52W High

SWOT Analysis

Heron Therapeutics Inc Live Price Chart

Heron Therapeutics Inc FAQ

How is Heron Therapeutics Inc today?

Heron Therapeutics Inc today is trading in the green, and is up by 1.00% at 2.02.

How has Heron Therapeutics Inc performed historically?

Heron Therapeutics Inc is currently trading up 1.00% on an intraday basis. In the past week the stock rose 6.88%. stock has been down -9.82% in the past quarter and fell -47.67% in the past year. You can view this in the overview section.